Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Baculoviral IAP Repeat-Containing-4 Protects Optic Nerve Axons in a Rat Glaucoma Model

1 Jun 2002

Abstract excerpt

Gene therapy represents an attractive approach for the treatment of eye diseases such as glaucoma. Ocular administration of viral vectors produces localized retinal gene expression with reduced risks of side effects reported with systemic administration of viral vectors. Recombinant adeno-associated viral (AAV) vectors have proven effective in producing long-term retinal gene expression, due to stable integration...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glaucoma and retinal disorders
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12027563
DOI: 10.1006/mthe.2002.0608

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Baculoviral IAP Repeat-Containing-4 Protects Optic Nerve Axons in a Rat Glaucoma ModelPMID 12027563Read ↗

The concept of gene therapy for glaucomaSemantic proximity Read ↗

Global Gene Expression Changes in Rat Retinal Ganglion Cells in Experimental GlaucomaSemantic proximity Read ↗

Restoring AIBP expression in the retina provides neuroprotection in glaucomaSemantic proximity Read ↗

rAAV prostaglandin-based gene therapy lowers intraocular pressure and preserves optic nerve health in glaucomatous DBA/2J miceSemantic proximity Read ↗

Dose-ranging and further therapeutic evaluation of a bicistronic humanized TrkB-BDNF gene therapy for glaucoma in rodentsSemantic proximity Read ↗

Comparative Evaluation of Adeno-Associated Virus and Lentivirus Mediated Gene Transfer in Adult Rat Optic NerveSemantic proximity Read ↗

Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapySemantic proximity Read ↗

Pigment Epithelium-Derived Factor Gene Therapy Targeting Retinal Ganglion Cell Injuries: Neuroprotection against Loss of Function in Two Animal ModelsSemantic proximity Read ↗

Neuritin1 <i>Cis</i> -Regulatory Elements Enable Gene Expression Preferentially in Retinal Ganglion CellsSemantic proximity Read ↗

Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell ApoptosisSemantic proximity Read ↗

Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucomaSemantic proximity Read ↗

Directed robust generation of functional retinal ganglion cells from Müller gliaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.